Feng Peng

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Hypertrophic Cardiomyopathy

Bariatric Surgery

Venous Thromboembolism

Top Venues

Oxidative medicine and cellular longevity

Obesity surgery

Cell death discovery

Genetic testing and molecular biomarkers

This page only lists publications with an associated author ORCID identifier.

Publications

Zhoufei Fang, Han Cai, Qixiang Zhang, Jin Gong, Wei Zhou, Liang-Di Xie, Feng Peng
Comparative Analysis of Single-Path and Multipath Adrenal Venous Sampling in Primary Aldosteronism. Journal of interventional cardiology 2023 (2023)
Dan Hu, Laicheng Wang, Xin Chen, Yunchai Lin, Shunpeng Zhang, Zongcheng Fan, Feng Peng
Impact of PIWIL1 Single Nucleotide Polymorphisms on Gastric Cancer Risk in a Chinese Population. Genetic testing and molecular biomarkers 27 (6) (2023)
Yunchai Lin, Hongping Xiong, Jinzi Su, Jinxiu Lin, Qiang Zhou, Meihua Lin, Wenxiang Zhao, Feng Peng
Effectiveness and safety of non-vitamin K antagonist oral anticoagulants in patients with hypertrophic cardiomyopathy with non-valvular atrial fibrillation. Heart and vessels 37 (7) (2022)
Jianjian Yu, Dan Hu, Laicheng Wang, Zongcheng Fan, Changsheng Xu, Yunchai Lin, Xin Chen, Jinxiu Lin, Feng Peng
Hyperglycemia induces gastric carcinoma proliferation and migration via the Pin1/BRD4 pathway. Cell death discovery 8 (1) (2022)
Laicheng Wang, Meihua Lin, Jianjian Yu, Zongcheng Fan, Shunpeng Zhang, Yunchai Lin, Xin Chen, Feng Peng
The Impact of Bariatric Surgery Versus Non-Surgical Treatment on Blood Pressure: Systematic Review and Meta-Analysis. Obesity surgery 31 (11) (2021)
Yuansheng Wu, Meijin Zhang, Changsheng Xu, Dajun Chai, Feng Peng, Jinxiu Lin
Anti-Diabetic Atherosclerosis by Inhibiting High Glucose-Induced Vascular Smooth Muscle Cell Proliferation via Pin1/BRD4 Pathway. Oxidative medicine and cellular longevity 2020 (2020)
Meijin Zhang, Liming Lin, Changsheng Xu, Dajun Chai, Feng Peng, Jinxiu Lin
VDR Agonist Prevents Diabetic Endothelial Dysfunction through Inhibition of Prolyl Isomerase-1-Mediated Mitochondrial Oxidative Stress and Inflammation. Oxidative medicine and cellular longevity 2018 (2018)